(NPO) Enpro Industries - Overview
Stock: Seals, Gaskets, Coatings, Bellows, Filters
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.62% |
| Yield on Cost 5y | 1.70% |
| Yield CAGR 5y | 3.51% |
| Payout Consistency | 100.0% |
| Payout Ratio | 24.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.4% |
| Relative Tail Risk | -2.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.98 |
| Alpha | 22.64 |
| Character TTM | |
|---|---|
| Beta | 1.422 |
| Beta Downside | 1.373 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.72% |
| CAGR/Max DD | 1.02 |
Description: NPO Enpro Industries January 10, 2026
Enpro Inc. (NYSE:NPO) is an industrial-technology firm that designs, develops, manufactures, and markets proprietary, value-added products for critical environments across the United States, Europe, Asia-Pacific, and other regions. The company operates two distinct segments: Sealing Technologies, which supplies a broad portfolio of hygienic seals, gaskets, hydraulic components, and custom mechanical seals for sectors ranging from food and pharma to nuclear energy and hydrogen processing; and Advanced Surface Technologies, which provides cleaning, coating, testing, and refurbishment services for semiconductor equipment, as well as thin-film optical filters, electrostatic chuck pedestals, and edge-welded metal bellows for aerospace, defense, and space applications.
Key drivers for Enpro include the accelerating global shift toward hydrogen as an energy carrier-boosting demand for high-integrity sealing solutions-and the sustained growth in semiconductor capital expenditures, which underpins the Advanced Surface Technologies segment’s service and coating revenue. In the most recent fiscal year, the company reported a 6% year-over-year revenue increase to $1.03 billion, with operating margins expanding to 9.2% as cost-discipline and higher-margin service contracts offset raw-material price volatility.
Investors seeking a data-rich, model-based perspective on Enpro’s valuation may find the ValueRay platform’s detailed analytics worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 86.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.58 > 1.0 |
| NWC/Revenue: 24.40% < 20% (prev 31.83%; Δ -7.43% < -1%) |
| CFO/TA 0.08 > 3% & CFO 197.9m > Net Income 86.4m |
| Net Debt (323.8m) to EBITDA (255.1m): 1.27 < 3 |
| Current Ratio: 2.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.3m) vs 12m ago 0.95% < -2% |
| Gross Margin: 42.71% > 18% (prev 0.42%; Δ 4229 % > 0.5%) |
| Asset Turnover: 44.86% > 50% (prev 41.02%; Δ 3.84% > 0%) |
| Interest Coverage Ratio: 4.46 > 6 (EBITDA TTM 255.1m / Interest Expense TTM 34.6m) |
Altman Z'' 4.25
| A: 0.11 (Total Current Assets 457.0m - Total Current Liabilities 187.1m) / Total Assets 2.40b |
| B: 0.51 (Retained Earnings 1.23b / Total Assets 2.40b) |
| C: 0.06 (EBIT TTM 154.2m / Avg Total Assets 2.47b) |
| D: 1.36 (Book Value of Equity 1.19b / Total Liabilities 877.7m) |
| Altman-Z'' Score: 4.25 = AA |
Beneish M -3.07
| DSRI: 0.97 (Receivables 139.5m/134.8m, Revenue 1.11b/1.04b) |
| GMI: 0.97 (GM 42.71% / 41.54%) |
| AQI: 1.01 (AQ_t 0.72 / AQ_t-1 0.72) |
| SGI: 1.06 (Revenue 1.11b / 1.04b) |
| TATA: -0.05 (NI 86.4m - CFO 197.9m) / TA 2.40b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of NPO shares?
Over the past week, the price has changed by +9.23%, over one month by +16.47%, over three months by +24.85% and over the past year by +40.16%.
Is NPO a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NPO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 252.3 | -5.7% |
| Analysts Target Price | 252.3 | -5.7% |
| ValueRay Target Price | 355.7 | 32.9% |
NPO Fundamental Data Overview February 05, 2026
P/E Forward = 27.027
P/S = 4.6745
P/B = 3.3069
P/EG = 1.7424
Revenue TTM = 1.11b USD
EBIT TTM = 154.2m USD
EBITDA TTM = 255.1m USD
Long Term Debt = 445.0m USD (from longTermDebt, last quarter)
Short Term Debt = 11.7m USD (from shortTermDebt, last quarter)
Debt = 456.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 323.8m USD (from netDebt column, last quarter)
Enterprise Value = 5.50b USD (5.17b + Debt 456.7m - CCE 132.9m)
Interest Coverage Ratio = 4.46 (Ebit TTM 154.2m / Interest Expense TTM 34.6m)
EV/FCF = 35.57x (Enterprise Value 5.50b / FCF TTM 154.5m)
FCF Yield = 2.81% (FCF TTM 154.5m / Enterprise Value 5.50b)
FCF Margin = 13.97% (FCF TTM 154.5m / Revenue TTM 1.11b)
Net Margin = 7.81% (Net Income TTM 86.4m / Revenue TTM 1.11b)
Gross Margin = 42.71% ((Revenue TTM 1.11b - Cost of Revenue TTM 633.8m) / Revenue TTM)
Gross Margin QoQ = 41.94% (prev 43.32%)
Tobins Q-Ratio = 2.29 (Enterprise Value 5.50b / Total Assets 2.40b)
Interest Expense / Debt = 1.51% (Interest Expense 6.90m / Debt 456.7m)
Taxrate = 32.71% (10.5m / 32.1m)
NOPAT = 103.8m (EBIT 154.2m * (1 - 32.71%))
Current Ratio = 2.44 (Total Current Assets 457.0m / Total Current Liabilities 187.1m)
Debt / Equity = 0.30 (Debt 456.7m / totalStockholderEquity, last quarter 1.52b)
Debt / EBITDA = 1.27 (Net Debt 323.8m / EBITDA 255.1m)
Debt / FCF = 2.10 (Net Debt 323.8m / FCF TTM 154.5m)
Total Stockholder Equity = 1.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.50% (Net Income 86.4m / Total Assets 2.40b)
RoE = 5.85% (Net Income TTM 86.4m / Total Stockholder Equity 1.48b)
RoCE = 8.02% (EBIT 154.2m / Capital Employed (Equity 1.48b + L.T.Debt 445.0m))
RoIC = 5.13% (NOPAT 103.8m / Invested Capital 2.02b)
WACC = 10.33% (E(5.17b)/V(5.63b) * Re(11.15%) + D(456.7m)/V(5.63b) * Rd(1.51%) * (1-Tc(0.33)))
Discount Rate = 11.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.71%
[DCF Debug] Terminal Value 69.87% ; FCFF base≈142.0m ; Y1≈140.6m ; Y5≈146.1m
Fair Price DCF = 68.75 (EV 1.77b - Net Debt 323.8m = Equity 1.45b / Shares 21.1m; r=10.33% [WACC]; 5y FCF grow -1.70% → 2.90% )
EPS Correlation: -50.97 | EPS CAGR: -48.14% | SUE: -3.96 | # QB: 0
Revenue Correlation: -6.87 | Revenue CAGR: 0.55% | SUE: 0.90 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.08 | Chg30d=-0.020 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=8.77 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+11.9% | Growth Revenue=+10.1%